1.705
price up icon0.29%   0.005
after-market アフターアワーズ: 1.71 0.005 +0.29%
loading

Pyxis Oncology Inc (PYXS) 最新ニュース

pulisher
Apr 12, 2026

PYXS | Pyxis Oncology, Inc. Common Insider Trading - Quiver Quantitative

Apr 12, 2026
pulisher
Apr 12, 2026

Growth Value: Will Pyxis Oncology Inc stock benefit from M ARate Cut & Weekly Stock Breakout Alerts - baoquankhu1.vn

Apr 12, 2026
pulisher
Apr 10, 2026

PYXS Stock Price, Quote & Chart | PYXIS ONCOLOGY INC (NASDAQ:PYXS) - ChartMill

Apr 10, 2026
pulisher
Apr 09, 2026

Stock Recap: Can Pyxis Oncology Inc benefit from deglobalization2026 Earnings & Verified Chart Pattern Signals - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 09, 2026

Price Action: Is Pyxis Oncology Inc part of any major index2026 Reactions & Low Drawdown Momentum Ideas - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 06, 2026

Trade Report: Can Pyxis Oncology Inc expand its profit marginsCPI Data & Safe Entry Momentum Stock Tips - baoquankhu1.vn

Apr 06, 2026
pulisher
Apr 05, 2026

Wall Street Zen Downgrades Pyxis Oncology (NASDAQ:PYXS) to Sell - marketbeat.com

Apr 05, 2026
pulisher
Apr 04, 2026

PYXS Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 04, 2026
pulisher
Apr 04, 2026

PYXS SEC FilingsPyxis Oncology, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 04, 2026
pulisher
Mar 31, 2026

PYXS Earnings History & Surprises | EPS & Revenue Results | PYXIS ONCOLOGY INC (NASDAQ:PYXS) - ChartMill

Mar 31, 2026
pulisher
Mar 30, 2026

Pyxis Oncology Inc. (PYXS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Mar 30, 2026
pulisher
Mar 29, 2026

Pyxis Oncology (PYXS) Receives a Rating Update from a Top Analyst - The Globe and Mail

Mar 29, 2026
pulisher
Mar 28, 2026

Pyxis Oncology (NASDAQ:PYXS) Stock Rating Upgraded by Wall Street Zen - marketbeat.com

Mar 28, 2026
pulisher
Mar 27, 2026

HC Wainwright Raises Earnings Estimates for Pyxis Oncology - Defense World

Mar 27, 2026
pulisher
Mar 26, 2026

Stock Report: Can Pyxis Oncology Inc expand its profit marginsDividend Hike & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 26, 2026

Q1 EPS Estimates for Pyxis Oncology Raised by HC Wainwright - MarketBeat

Mar 26, 2026
pulisher
Mar 26, 2026

HC Wainwright Expects Increased Earnings for Pyxis Oncology - Defense World

Mar 26, 2026
pulisher
Mar 25, 2026

Pyxis Oncology director Humphrey sells $15917 in shares By Investing.com - Investing.com Australia

Mar 25, 2026
pulisher
Mar 25, 2026

Pyxis Oncology (PYXS) director receives 45,867 stock options at $1.36 strike - Stock Titan

Mar 25, 2026
pulisher
Mar 25, 2026

Pyxis Oncology director Humphrey sells $15917 in shares - Investing.com UK

Mar 25, 2026
pulisher
Mar 25, 2026

Pyxis Oncology (PYXS) grants director Jakob Dupont 45,867 stock options - stocktitan.net

Mar 25, 2026
pulisher
Mar 25, 2026

Executive at Pyxis Oncology (PYXS) receives new option and RSU equity grants - stocktitan.net

Mar 25, 2026
pulisher
Mar 25, 2026

Pyxis Oncology (PYXS) director receives grant of 45,867 stock options - Stock Titan

Mar 25, 2026
pulisher
Mar 25, 2026

[Form 4] Pyxis Oncology, Inc. Insider Trading Activity - Stock Titan

Mar 25, 2026
pulisher
Mar 25, 2026

Director at Pyxis Oncology (PYXS) receives grant of 45,867 stock options - Stock Titan

Mar 25, 2026
pulisher
Mar 25, 2026

Pyxis Oncology (NASDAQ:PYXS) Director Rachel Humphrey Sells 13,896 Shares - MarketBeat

Mar 25, 2026
pulisher
Mar 25, 2026

Pyxis Oncology (PYXS) director sells 15,496 shares under 10b5-1 plan - Stock Titan

Mar 25, 2026
pulisher
Mar 25, 2026

FY2029 EPS Estimates for Pyxis Oncology Lifted by Analyst - MarketBeat

Mar 25, 2026
pulisher
Mar 24, 2026

LifeSci Capital Maintains Pyxis Oncology(PYXS.US) With Buy Rating, Maintains Target Price $5 - Moomoo

Mar 24, 2026
pulisher
Mar 24, 2026

A Quick Look at Today's Ratings for Pyxis Oncology(PYXS.US), With a Forecast Between $5 to $7 - Moomoo

Mar 24, 2026
pulisher
Mar 24, 2026

Stifel Nicolaus Lowers Pyxis Oncology (NASDAQ:PYXS) Price Target to $8.00 - marketbeat.com

Mar 24, 2026
pulisher
Mar 24, 2026

Stifel cuts Pyxis Oncology stock price target on financing assumptions By Investing.com - Investing.com India

Mar 24, 2026
pulisher
Mar 24, 2026

Pyxis Oncology (NASDAQ:PYXS) Given Buy Rating at HC Wainwright - MarketBeat

Mar 24, 2026
pulisher
Mar 24, 2026

Guggenheim reiterates Buy on Pyxis Oncology stock ahead of trial data By Investing.com - Investing.com South Africa

Mar 24, 2026
pulisher
Mar 24, 2026

Guggenheim reiterates Buy on Pyxis Oncology stock ahead of trial data - Investing.com India

Mar 24, 2026
pulisher
Mar 24, 2026

H.C. Wainwright reiterates Buy on Pyxis Oncology stock, $7 target By Investing.com - Investing.com India

Mar 24, 2026
pulisher
Mar 24, 2026

H.C. Wainwright reiterates Buy on Pyxis Oncology stock, $7 target - Investing.com

Mar 24, 2026
pulisher
Mar 24, 2026

Pyxis Oncology (PYXS) Rating Reiterated as Buy by HC Wainwright & Co. | PYXS Stock News - GuruFocus

Mar 24, 2026
pulisher
Mar 24, 2026

RBC Capital Initiates Pyxis Oncology(PYXS.US) With Buy Rating, Announces Target Price $5 - Moomoo

Mar 24, 2026
pulisher
Mar 24, 2026

Stifel cuts Pyxis Oncology stock price target on financing assumptions - Investing.com

Mar 24, 2026
pulisher
Mar 24, 2026

Pyxis Oncology Reports 2025 Financial Results, Advances MICVO Cancer Trials, and Announces New Leadership - Minichart

Mar 24, 2026
pulisher
Mar 23, 2026

Pyxis Oncology Reports Q4 Results, Advances MICVO Program - TipRanks

Mar 23, 2026
pulisher
Mar 23, 2026

William Blair reiterates Pyxis Oncology stock rating on trial pace By Investing.com - Investing.com Canada

Mar 23, 2026
pulisher
Mar 23, 2026

William Blair reiterates Pyxis Oncology stock rating on trial pace - Investing.com UK

Mar 23, 2026
pulisher
Mar 23, 2026

Jefferies raises Pyxis Oncology stock price target on drug data By Investing.com - Investing.com Australia

Mar 23, 2026
pulisher
Mar 23, 2026

Jefferies raises Pyxis Oncology stock price target on drug data - Investing.com

Mar 23, 2026
pulisher
Mar 23, 2026

MicuRx Pharmaceuticals: Advancing Novel ADC Therapy MICVO for Difficult-to-Treat Head and Neck Cancer – Pipeline, Strategy, and Risks Overview - Minichart

Mar 23, 2026
pulisher
Mar 23, 2026

Pyxis Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 23, 2026
pulisher
Mar 23, 2026

Pyxis Oncology (NASDAQ:PYXS) Posts Earnings Results, Beats Expectations By $0.06 EPS - MarketBeat

Mar 23, 2026
$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.83
price up icon 1.38%
$152.05
price up icon 3.43%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
大文字化:     |  ボリューム (24 時間):